Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

GUB014295

A Two-Part First-In-Human Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GUB014295

AbbVie · Phase 1 · Completed · Enrollment 76

NCT06144684

ArmPopulationDoseWeeksEstimandWeight change
PlaceboObesity or overweightn/rn/rn/rn/r
GUB014295Obesity or overweightn/rn/rn/rn/r